CDT EQUITY INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CDT EQUITY INC. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CDT EQUITY INC. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $530.00K, a 76.04% decline year-over-year.
- CDT EQUITY INC. stock issued during period, value, issued for services for the quarter ending 2025-12-31 was -$1.80M, a 2056.52% decline year-over-year.
- CDT EQUITY INC. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $0.00.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: S-1 6 month − 10-Q 3 month · filed 2026-09-08 | -$1.27M derived: sum of 4 quarters · filed 2026-09-08 |
| 2026-03-31 | $530.00K 10-Q · filed 2026-07-15 | -$530.00K derived: sum of 4 quarters · filed 2026-09-08 |
| 2025-12-31 | -$1.80M derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | $1.15M S-1 · filed 2026-09-08 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − S-1 6 month · filed 2025-11-13 | $3.04M derived: sum of 4 quarters · filed 2026-09-08 |
| 2025-06-30 | $740.00K S-1 · filed 2026-09-08 | $3.04M derived: sum of 4 quarters · filed 2026-09-08 |
| 2025-03-31 | $2.21M 10-Q · filed 2026-07-15 | $2.45M derived: sum of 4 quarters · filed 2026-09-08 |
| 2024-12-31 | $92.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-08 | $242.00K S-1 · filed 2026-09-08 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | |
| 2024-06-30 | $150.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |